disposit acid olsalazin mesalazin prepar patient ulcer coliti comparison intralumin colon concentr serum valu urinari excret disposit acid acetyl metabolit treatment olsalazin mesalazin patient inact ulcer coliti mesalazin asacol mg pentasa mg salofalk mg crossov design trial drug day intralumin colon concentr day method equilibrium vivo dialysi faec predos serum sampl hour urin collect day acid valu high perform liquid chromatographi olsalazin colon concentr mean sem mmol/l activ ingredi equimolar dose pentasa mmol/l salofalk mmol/l time olsalazin treatment serum concentr urinari excret mesalazin prepar low system load olsalazin reduc potenti risk nephrotox long term treatment 